IL40458A0 - Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents

Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL40458A0
IL40458A0 IL40458A IL4045872A IL40458A0 IL 40458 A0 IL40458 A0 IL 40458A0 IL 40458 A IL40458 A IL 40458A IL 4045872 A IL4045872 A IL 4045872A IL 40458 A0 IL40458 A0 IL 40458A0
Authority
IL
Israel
Prior art keywords
hydroxypyrimidines
pyrimidinones
novel
preparation
pharmaceutical compositions
Prior art date
Application number
IL40458A
Other versions
IL40458A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL40458A0 publication Critical patent/IL40458A0/en
Publication of IL40458A publication Critical patent/IL40458A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL40458A 1971-10-29 1972-09-28 Pyrimidinones,their preparation and pharmaceutical compositions containing them IL40458A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (2)

Publication Number Publication Date
IL40458A0 true IL40458A0 (en) 1972-11-28
IL40458A IL40458A (en) 1976-05-31

Family

ID=22715935

Family Applications (2)

Application Number Title Priority Date Filing Date
IL40458A IL40458A (en) 1971-10-29 1972-09-28 Pyrimidinones,their preparation and pharmaceutical compositions containing them
IL48790A IL48790A (en) 1971-10-29 1976-01-05 Hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL48790A IL48790A (en) 1971-10-29 1976-01-05 Hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT321308B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH555832A (en)
DE (3) DE2248741C3 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377720A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL84634B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
JPS5752409Y2 (en) * 1979-11-05 1982-11-15
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
NZ565955A (en) 2005-08-22 2011-08-26 Melior Pharmaceuticals I Inc Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
NZ758966A (en) 2017-04-10 2024-08-30 Board Of Supervisors Of Louisiana State Univ And Agricultural And Mechanical College Treatment of adipocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
FI55503C (en) 1979-08-10
NO136574C (en) 1977-09-28
JPS5422995B2 (en) 1979-08-10
NL166470B (en) 1981-03-16
DE2248741C3 (en) 1975-06-26
DE2264374A1 (en) 1973-05-24
LU66304A1 (en) 1973-05-03
AU467600B2 (en) 1975-12-04
GB1377720A (en) 1974-12-18
SE397090B (en) 1977-10-17
AR198798A1 (en) 1974-07-24
JPS4852780A (en) 1973-07-24
AT321308B (en) 1975-03-25
GB1377308A (en) 1974-12-11
DE2248741A1 (en) 1973-05-03
PL89852B1 (en) 1976-12-31
IL40458A (en) 1976-05-31
ES407730A1 (en) 1976-01-16
IL48790A (en) 1976-05-31
DK131465C (en) 1975-12-08
FR2157865A1 (en) 1973-06-08
PH11594A (en) 1978-03-31
IE37043B1 (en) 1977-04-27
BE790125A (en) 1973-04-16
AT320656B (en) 1975-02-25
NL166470C (en) 1981-08-17
SE7505279L (en) 1975-05-06
JPS5337870B2 (en) 1978-10-12
FR2157865B1 (en) 1975-10-31
NO136574B (en) 1977-06-20
PL84634B1 (en) 1976-04-30
DK131465B (en) 1975-07-21
YU255172A (en) 1980-03-15
PH10129A (en) 1976-09-02
DE2264374C3 (en) 1981-07-23
SU498908A3 (en) 1976-01-05
YU35125B (en) 1980-09-25
EG11013A (en) 1976-11-30
IL48790A0 (en) 1976-03-31
DE2264657A1 (en) 1974-06-20
SE393376B (en) 1977-05-09
ES436624A1 (en) 1977-02-01
CA980778A (en) 1975-12-30
YU99179A (en) 1981-08-31
ZA727362B (en) 1973-11-28
DE2264374B2 (en) 1980-08-07
DE2248741B2 (en) 1974-11-14
AU4722872A (en) 1974-04-04
CH549579A (en) 1974-05-31
IE37043L (en) 1973-04-29
JPS53116386A (en) 1978-10-11
NL7213959A (en) 1973-05-02
AR196263A1 (en) 1973-12-10
CH555832A (en) 1974-11-15
YU36295B (en) 1982-06-18
FI55503B (en) 1979-04-30
DE2264657C2 (en) 1982-09-16
SU505362A3 (en) 1976-02-28

Similar Documents

Publication Publication Date Title
IL45492A0 (en) New pyrimidines,their preparation and pharmaceutical compositions containing them
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
IL40686A0 (en) Triazinone derivatives,their preparation and pharmaceutical compositions containing them
IL36237A0 (en) Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them
IL39341A0 (en) Novel thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IL38705A0 (en) Novel pyridazinones,their preparation and pharmaceutical compositions containing them
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
IL43001A0 (en) Novel 4-biphenylyl-alcohols,their preparation and pharmaceutical compositions containing them
IL37598A0 (en) Bis-chromonyloxy compounds,their preparation and pharmaceutical compositions containing them
IL39845A0 (en) Novel quinazolinone derivatives,their preparation and pharmaceutical compositions containing them
IL40458A0 (en) Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them
IL49286A0 (en) Novel 1-iodo-1-trans-alkenes,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
ZA725890B (en) Pyrimidine derivatives and pesticidal compositions containing them
IL40559A0 (en) Novel pyrido(2,3-d)pyrimidines their preparation and pharmaceutical compositions containing them
IL36743A (en) Phenylaminoalkanes,their preparation and pharmaceutical compositions containing them
IL37588A0 (en) Pyrimidoisoquinolines,their preparation and pharmaceutical compositions containing them
IL40886A0 (en) Novel benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
IL38440A0 (en) Substituted dioxypiperidines,their preparation and pharmaceutical compositions containing them
IL41034A0 (en) Novel 6-aza-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them
IL37047A0 (en) Substituted amidines,their preparation and pharmaceutical compositions containing them
IL45865A0 (en) 4-oxo-2-imidazolidinylidene ureas,their preparation and pharmaceutical compositions containing them
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them